(Press-News.org) UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award. Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, and Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, are principal investigators on a $3.07 million grant from the National Cancer Institute for a project to develop a new series of drugs targeting microtubules to stop the spread of breast cancer to the brain and bone. Duane Miller, PhD, professor emeritus, and Zhongzhi Wu, PhD, assistant professor, both in the Department of Pharmaceutical Sciences in the College of Pharmacy, are co-investigators.
A major clinical challenge in breast cancer care is treating metastatic disease, particularly brain and bone metastases. Mainline therapies, including conventional chemotherapeutic drugs targeting microtubules such as taxanes, have low brain penetration, often are subject to drug resistance, and have long-term side-effects, such as neurotoxicity.
Dr. Li and Dr. Miller have been working together for over 10 years to develop a new generation of tubulin inhibitors for various cancer types. Their efforts led to an investigational new drug, sabizabulin, which suppresses primary tumor growth and metastasis in several types of tumor models and is effective in overcoming taxane resistance. Over the past five years, Dr. Li and Dr. Miller collaborated with Dr. Seagroves to evaluate these tubulin inhibitors for late-stage breast cancer. In their recent studies, the team found that modified sabizabulin analogs have high brain penetrability and excellent efficacy in multiple taxane-resistant tumor models.
The goals of this new project are to structurally optimize this class of analogs for potency and the ability to penetrate the brain, and to create novel analog drug conjugates (made by joining a cancer drug molecule to another molecule that preferentially interacts with a specific type of cell in the body). For treating bone metastases, Drs. Li and Seagroves will conjugate new sabizabulin analogs with bisphosphonates, a drug class used to increase bone strength. They will test the optimal conjugate by comparing it to a reference chemotherapy in animals with bone-destroying breast cancer.
“The addition of a new generation of tubulin inhibitor to the existing panel of chemotherapeutic drugs could help to improve metastatic breast cancer patient overall survival and quality of life,” Dr. Li said. “In addition, patients diagnosed with other types of metastatic solid tumors in which tubulin inhibitors are currently standard of care could also benefit.”
END
Breast cancer research team pulls in $3 million in national support
2023-06-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Science in the shadows: NASA selects 5 experiments for 2024 total solar eclipse
2023-06-20
A total solar eclipse will darken a swath of North America as the Moon blocks the light of the Sun for a few minutes on April 8, 2024. In addition to casting a breathtaking, passing shadow over the heads of millions of people, this total solar eclipse gives scientists a unique opportunity to study the Sun, Earth, and their interactions.
NASA will fund five interdisciplinary science projects for the 2024 eclipse to make the most of this opportunity. The projects, which are led by researchers at different academic institutions, will study the Sun and its influence on Earth with a variety of instruments, including cameras aboard high-altitude research planes, ham radios, and ...
Dupilumab lessens disease in COPD patients with type 2 inflammation
2023-06-20
BIRMINGHAM, Ala. – Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab, according to a yearlong, Phase 3 clinical trial reported in the New England Journal of Medicine.
These improvements — as measured by a significantly lower annualized rate of acute exacerbations, significantly better lung function and quality of life, and significantly less severe symptoms than placebo-treated adults with COPD — were observed within two to four weeks after the initiation of dupilumab and were sustained throughout the 52-week trial period. This monoclonal antibody ...
Scientists discover new embryonic cell type that self-destructs to protect the developing embryo
2023-06-20
Scientists studying gene activity data of the early human embryo have discovered an overlooked type of cell which self-destructs within days of forming, as part of a quality control process to protect the developing foetus. The findings give insights on what happens at the very first stages of life after fertilisation which could in the future help improve IVF or regenerative medicine treatments.
A new study published on 20 June 2023 in PLoS Biology by an international team of scientists including researchers at the University of Bath, finds that our earliest development in the womb may be rather different to what we have always assumed.
While ...
National Geographic Explorers win award for visualizing arctic climate change
2023-06-20
FOR IMMEDIATE RELEASE: June 20, 2023 - Washington, D.C. - An innovative virtual reality project created by National Geographic Explorers in collaboration with local communities was recognized with the “Best in Category: Visualize” during the XR Prize Challenge: Fight Climate Change earlier this month. The project, “Qikiqtaruk: Arctic at Risk” was selected for the award from across 150 submissions at the Augmented World Expo (AWE) in Santa Clara, California on June 1, 2023.
“Qikiqtaruk: Arctic at Risk” brought together researchers, park rangers, educators and immersive content ...
NYU Abu Dhabi researchers develop first-of-its-kind adhesive bandage that can detect COVID-19 antibodies
2023-06-20
Abu Dhabi, UAE, June 20, 2023: Researchers at NYU Abu Dhabi have developed a new rapid testing method for COVID-19 – an adhesive bandage that relies on gold nanoparticles to quickly detect the immune antibodies in the bloodstream.
These antibodies, named IgM and IgG, are naturally produced as a result of SARS-CoV-2 infection, and therefore serve as valuable biomarkers to identify infected individuals and monitor the spread of pandemics. The innovative bandage technology is affordable and easy-to-use, and ...
Alissa Park appointed Dean of UCLA Henry Samueli School of Engineering and Applied Science
2023-06-20
Ah-Hyung “Alissa” Park has been appointed the Ronald and Valerie Sugar Dean of the UCLA Henry Samueli School of Engineering and Applied Science, effective September 1.
One of the nation’s leading experts on carbon capture and conversion technology, Park is currently the Lenfest Earth Institute Professor of Climate Change and chair of the department of earth and environmental engineering at Columbia University, where she has been a faculty member since 2007. She also is director of the Lenfest Center for Sustainable Energy, an executive committee ...
Research identifies factors that make correcting misinformation about science more successful
2023-06-20
In an article titled “A Meta-analysis of Correction Effects in Science-Relevant Misinformation” published in the journal Nature Human Behaviour, University of Pennsylvania social psychologists and communication scholars Man-pui Sally Chan and Dolores Albarracín explain the circumstances under which corrections of misinformation about science are most likely to work or fail, as well as the characteristics of the corrections most likely to succeed.
The authors conducted a meta-analysis, a quantitative synthesis of prior research, which involved 60,000 ...
Wider access to health insurance via Medicaid expansion improved cardiac care
2023-06-20
Research Highlights:
States that participated in the Medicaid expansion provision of the Affordable Care Act, raising the income level to be eligible for Medicaid up to 138% of the federal poverty level, improved several measures of heart disease care for Medicaid recipients in their states.
In an analysis of 30 studies comparing states that chose to participate in Medicaid expansion with those that didn’t, Medicaid expansion was associated with improvement in insurance coverage for cardiac care, decreased out-of-hospital deaths, fewer socioeconomic and demographic disparities in care and increased preventive care and screening.
Embargoed until 1 p.m. CT/2 p.m. ET, ...
Less-invasive cardiac MRI is a valuable diagnostic tool in the early evaluation of patients with acute chest pain
2023-06-20
WINSTON-SALEM, N.C. – June 20, 2023 – An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly elevated troponin levels. High levels of troponin, a protein, occur when the heart muscle is damaged from a heart attack. How best to evaluate and treat patients with chest pain with detectable or mildly elevated troponin remains unclear.
Now, a new study from researchers at Wake Forest University School of Medicine reveals that cardiac magnetic resonance imaging (MRI), is a safe and valuable tool to help evaluate these complex patients.
The ...
Novel way to manipulate exotic materials
2023-06-20
An advance in a topological insulator material — whose interior behaves like an electrical insulator but whose surface behaves like a conductor — could revolutionize the fields of next-generation electronics and quantum computing, according to scientists at Oak Ridge National Laboratory.
Discovered in the 1980s, a topological material is a new phase of material whose discoverers received a Nobel Prize in 2016. Using only an electric field, ORNL researchers have transformed a normal insulator into a magnetic topological insulator. This exotic material allows electricity ...